The finding was that 1 to 4–5 years of cumulative exposure to prolactin-sparing antipsychotics (clozapine, quetiapine, or aripiprazole), i.e., small amounts of extra prolactin, did not increase the risk for breast cancer. This evidence concerns the gene PRL and breast cancer.